Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
US6632835B2 · kind B2 · utility
3Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2001 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Aug 21, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/912
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Molecules demonstrating anti-proliferative effects against epithelial cancer cell lines and endothelial cells and methods of synthesis are disclosed. The molecules are intended for use in therapeutic preparations for the treatment of cancer through either anti-angiogenesis or other anti-cancer mechanisms. The compounds specified are 6H-dibenzo[b,d]pyran-6-one derivatives and have been shown to be antiproliferative against human endothelial cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.